test

Ron Rosenstraus

@Eversept Partners, Lp

Latest period2024 - Q3ReportedManaged Assets$1.46BTotal holdings67
Assets growth rate-0.03%Assets growth rate (2-Q avg)-1.3%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Eversept Partners, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 67 positions.

Assets under management

The assets under management (AUM) of Eversept Partners, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.46B in assets, with a quarterly growth rate of -0.03% and a 2-quarter average growth rate of -1.3%. The portfolio is managed by Ron Rosenstraus, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
ITCIIntra-cellular Therapies Inc
Recent Activity
New Position
0.63%
$9.109M
124,491 shares@ $73.17 avg price
EOLSEvolus Inc
Recent Activity
Decreased -21.13%
0.51%
$7.34M
453,061 shares@ $16.2 avg price
BHVNBiohaven Ltd
Recent Activity
New Position
0.46%
$6.623M
132,537 shares@ $49.98 avg price
ARQTArcutis Biotherapeutics Inc
Recent Activity
Decreased -17.25%
0.45%
$6.447M
693,263 shares@ $9.31 avg price
STROSutro Biopharma Inc
Recent Activity
Increased 5.92%
0.44%
$6.373M
1.842M shares@ $3.47 avg price
BKDBrookdale Sr Living Inc
Recent Activity
Decreased -44.32%
0.41%
$5.848M
861,268 shares@ $6.8 avg price
NAMSNewamsterdam Pharma Company
Recent Activity
Decreased -6.83%
0.35%
$5.102M
307,357 shares@ $16.6 avg price
FNAParagon 28 Inc
Recent Activity
New Position
0.35%
$5.005M
749,213 shares@ $6.69 avg price
GOSSGossamer Bio Inc
Recent Activity
Decreased -9.22%
0.34%
$4.911M
4.978M shares@ $0.99 avg price
TSVT2seventy Bio Inc
Recent Activity
Decreased -9.89%
0.33%
$4.711M
998,079 shares@ $4.73 avg price